Mauro G Papotti
Overview
Explore the profile of Mauro G Papotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyberis P, Verri G, Solidoro P, Femia F, Perotti C, Limerutti G, et al.
Minerva Surg
. 2023 May;
79(2):133-139.
PMID: 37218142
Background: According to current guidelines, a surgical biopsy is rarely required when a high-confidence radiologic interstitial lung disease (ILD) diagnosis is made on thin-section high-resolution computed tomography (HRCT). Nevertheless, disowning...
2.
Mete O, Erickson L, Juhlin C, de Krijger R, Sasano H, Volante M, et al.
Endocr Pathol
. 2022 Mar;
33(1):155-196.
PMID: 35288842
The new WHO classification of adrenal cortical proliferations reflects translational advances in the fields of endocrine pathology, oncology and molecular biology. By adopting a question-answer framework, this review highlights advances...
3.
Baloch Z, Asa S, Barletta J, Ghossein R, Juhlin C, Jung C, et al.
Endocr Pathol
. 2022 Mar;
33(1):27-63.
PMID: 35288841
This review summarizes the changes in the 5th edition of the WHO Classification of Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new classification has divided thyroid...
4.
Marx A, Chan J, Chalabreysse L, Dacic S, Detterbeck F, French C, et al.
J Thorac Oncol
. 2021 Oct;
17(2):200-213.
PMID: 34695605
This overview of the fifth edition of the WHO classification of thymic epithelial tumors (including thymomas, thymic carcinomas, and thymic neuroendocrine tumors [NETs]), mediastinal germ cell tumors, and mesenchymal neoplasms...
5.
Barreca A, Bottasso E, Veneziano F, Giarin M, Nocifora A, Martinetti N, et al.
PLoS One
. 2021 Aug;
16(8):e0256306.
PMID: 34428239
Amyloidosis comprises a spectrum of disorders characterized by the extracellular deposition of amorphous material, originating from an abnormal serum protein. The typing of amyloid into its many variants represents a...
6.
Anobile D, Bironzo P, Picca F, Lingua M, Morena D, Righi L, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34066159
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive cancer generally diagnosed at an advanced stage and characterized by a poor prognosis. The absence of alterations in druggable kinases, together...
7.
Liberini V, Huellner M, Grimaldi S, Finessi M, Thuillier P, Muni A, et al.
Diagnostics (Basel)
. 2020 Dec;
10(12).
PMID: 33322819
The NETTER-1 study has proven peptide receptor radionuclide therapy (PRRT) to be one of the most effective therapeutic options for metastatic neuroendocrine tumors (NETs), improving progression-free survival and overall survival....
8.
Baloch Z, Seethala R, Faquin W, Papotti M, Basolo F, Fadda G, et al.
Cancer Cytopathol
. 2016 May;
124(9):616-20.
PMID: 27203786
No abstract available.
9.
Duregon E, Molinaro L, Volante M, Ventura L, Righi L, Bolla S, et al.
Mod Pathol
. 2014 Jan;
27(9):1246-54.
PMID: 24434900
Mitotic count on hematoxylin and eosin slides is a fundamental morphological criterion in the diagnosis and grading of adrenocortical carcinoma in any scoring system employed. Moreover, it is the unique...
10.
Righi L, Papotti M, Ceppi P, Bille A, Bacillo E, Molinaro L, et al.
J Clin Oncol
. 2010 Feb;
28(9):1534-9.
PMID: 20177021
Purpose: The relationship between thymidylate synthase (TS) expression and outcome in patients with malignant pleural mesothelioma (MPM) treated with pemetrexed (P) was retrospectively evaluated. Patients And Methods: Sixty histologically confirmed...